Hogan SL - Search Results

1

The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney Disease.

Tuey SM, Prebehalla L, Roque AA, Roda G, Chonchol MB, Shah N, Wempe MF, Hu Y, Hogan SL, Nolin TD, Joy MS. Tuey SM, et al. Among authors: hogan sl. J Clin Pharmacol. 2022 Dec;62(12):1528-1538. doi: 10.1002/jcph.2104. Epub 2022 Jul 9. J Clin Pharmacol. 2022. PMID: 35678297

2

Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials.

Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE. Kshirsagar AV, et al. Among authors: hogan sl. Am J Kidney Dis. 2000 Apr;35(4):695-707. doi: 10.1016/s0272-6386(00)70018-7. Am J Kidney Dis. 2000. PMID: 10739792 Clinical Trial.

3

Long-term glycemic control measurements in diabetic patients receiving hemodialysis.

Joy MS, Cefalu WT, Hogan SL, Nachman PH. Joy MS, et al. Among authors: hogan sl. Am J Kidney Dis. 2002 Feb;39(2):297-307. doi: 10.1053/ajkd.2002.30549. Am J Kidney Dis. 2002. PMID: 11840370 Clinical Trial.

4

Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.

Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Dornbrook-Lavender KA, et al. Among authors: hogan sl. Pharmacotherapy. 2005 Mar;25(3):335-44. doi: 10.1592/phco.25.3.335.61599. Pharmacotherapy. 2005. PMID: 15843280 Clinical Trial.

5

Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein.

Joy MS, Nickeleit V, Hogan SL, Thompson BD, Finn WF. Joy MS, et al. Among authors: hogan sl. Pharmacotherapy. 2005 Jun;25(6):779-89. doi: 10.1592/phco.2005.25.6.779. Pharmacotherapy. 2005. PMID: 15927895

6

A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH. Joy MS, et al. Among authors: hogan sl. Nephrol Dial Transplant. 2005 Dec;20(12):2725-32. doi: 10.1093/ndt/gfi117. Epub 2005 Sep 27. Nephrol Dial Transplant. 2005. PMID: 16188901

7

Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.

Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Joy MS, et al. Among authors: hogan sl. Nephrol Dial Transplant. 2007 Jul;22(7):1963-8. doi: 10.1093/ndt/gfm133. Epub 2007 Mar 29. Nephrol Dial Transplant. 2007. PMID: 17395652

8

Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.

Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Joy MS, et al. Among authors: hogan sl. Pharmacotherapy. 2007 May;27(5):734-44. doi: 10.1592/phco.27.5.734. Pharmacotherapy. 2007. PMID: 17461709

9

Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Lionaki S, et al. Among authors: hogan sl. Nephrol Dial Transplant. 2007 Dec;22(12):3508-15. doi: 10.1093/ndt/gfm493. Epub 2007 Aug 8. Nephrol Dial Transplant. 2007. PMID: 17686815

10

Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.

Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C. Joy MS, et al. Among authors: hogan sl. Ann Pharmacother. 2008 Jan;42(1):9-15. doi: 10.1345/aph.1K407. Epub 2007 Nov 13. Ann Pharmacother. 2008. PMID: 18000162 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page